Concentrated EMDR: A case study of EMDR with co-morbid depression and anxiety
The efficacy of EMDR treatment for PTSD is established. EMDR is globally recognized as a level one evidence-based practice for PTSD. The studies that were used to determine these findings tended to have weekly EMDR sessions; however it may be possible that more frequent sessions could produce more effective outcomes. This pilot study investigated concentrated EMDR treatment using a quantitative single case study design with a participant with co-morbid major depressive disorder, severe without psychotic features and panic disorder with agoraphobia. The purpose of this pilot study was to determine concentrated EMDR treatment warrants further research attention. The researcher used the Beck's Depression Inventory and The Beck's Anxiety Inventory as the outcome measures. A non-predetermined treatment trial of twelve EMDR reprocessing treatment sessions occurred at a frequency of three 90 minutes sessions per week for a period of one month. Thc baseline mean scores were. BAI: M=38, BDI: M=49. At a 3-month follow-up the scores decrease to raw outcome scores of BAI: 7; BDI: 8. The results of this pilot study are significant in indicating that (a) concentrated EMDR may promote favorable treatmenr outcomes and (b) concentrated EMDR may be effective in treating co-morbid major depressive disorder, severe without psychotic features and panic with agoraphobia.
Original Work Citation
Grey, E. (2010, September/October). Concentrated EMDR: A case study of EMDR with co-morbid depression and anxiety. Poster presented at the 15th EMDR International Association Conference, Minneapolis, MN
“Concentrated EMDR: A case study of EMDR with co-morbid depression and anxiety,” Francine Shapiro Library, accessed November 25, 2020, https://emdria.omeka.net/items/show/20377.